February 11, 2020
For Immediate Release
Deborah Duffey, President
Dermazone Solutions Recognized at Nano Florida International Conference
ST. PETERSBURG, FLA. Dermazone Solutions is pleased to announce that its Formula Development Division tied for third place in the poster category on Nano-biotechnology, Tissue Engineering, and Nano pharmaceutics at the NanoFlorida International Conference. Participants included Jeffrey Reynolds, Senior Director of Research and Development, Nicole McCardy, director of R&D Formulation Chemist II and Dr. Julian Bejarano. The NanoFlorida International Conference occurred on 15-17 November 2019 and draws attendees from across the globe, from academics, researchers, and industrial practices using nanotechnologies. The conference is conceived to help build collaborations among nanoscience specialists while connecting professional and academic experts through a venue designed to enable research sharing of induvial and group efforts.
The Dermazone poster was a review of research completed demonstrating the benefit of our nano-lipidic particle technology as enhancing topical delivery of an active ingredient. We chose cannabidiol (CBD) encapsulated in our NLP technology, added to a regular lotion formulation. When this product was compared to an equivalent formula (without NLP), under confocal Raman microscopy, the data was irrefutable, demonstrating that the presence of NLP enabled faster, deeper and greater concentration of CBD to penetrate into the skin. After 3 hours and 20 hours, the differences between the formula with and without NLP were dramatic.
“It is an honor to be recognized by the NanoFlorida International Conference (2019) for having an outstanding poster,” says Deborah Duffey, President, Dermazone Solutions.” Our leadership in nano-lipidic encapsulation spans over 20 years and has produced over a dozen patents with many more applications in the pipeline. Our new discovery allows our technology platform to expand into many consumer product applications from skin science to animal health. Our passion to enrich lives with our technology drives our daily innovations.”
About Dermazone Solutions
Dermazone Solutions, Inc. is a leader in the field of nanotechnology and holds patents on its proprietary nanosphere delivery systems, which are integral to its Celazome, Kara Vita and Hyssop Health product lines. The company’s state-of-the-art manufacturing facility is FDA-registered and can offer a wide range of product services including formulating, private labeling, contract manufacturing, packaging and fulfillment for pharmaceuticals and cosmeceuticals. Dermazone is located in St. Petersburg, Florida. For more information, visit www.dermazone.com.